查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1268814

3D 生物打印市场规模、份额、趋势分析报告，按技术（磁悬浮、基于喷墨）、按应用（医疗、牙科、生物传感器、生物墨水）、按地区、细分趋势，2023-2030 年

3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based), By Application (Medical, Dental, Biosensors, Bioinks), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 109 Pages | 商品交期: 2-10个工作天内

价格

3D 生物打印市场增长和趋势：

Grand View Research, Inc. 的最新报告预测，到 2030 年全球 3D 生物打印市场规模将达到 53 亿美元，预测期内以 12.5% 的复合年增长率扩张。

COVID-19 病例的增加和慢性病的高患病率是促进增长的主要因素。 在大流行期间，3D 打印已成为改善医疗保健和支持应急响应的关键技术。

自 2019 年 12 月在中国首次发现以来，COVID-19 流行病一直呈上升趋势。 截至 2021 年 1 月 12 日，全球已报告超过 9150 万例 COVID-19 病例，超过 1,956,880 例死亡。 大流行加速了疫苗和药物试验的开发。

与此同时，各3D生物打印公司都在专注于人造组织的研发。 使用 U-FAB 和其他生物打印技术，CLECELL 创造了工程呼吸上皮细胞，利用粘膜纤毛升降机来防止感染和组织损伤。

大流行不仅影响了人们的福祉，还影响了全球经济和各种医疗保健基础设施。 它还严重扰乱了全球医疗设备和药品的供应链。 在这样的危机中，各种 3D 生物打印公司发起了一项全球运动，为医护人员提供紧急医疗设备，例如呼吸机和个人防护设备 (PPE)。

北美将在 2022 年占据约 30.9% 的最高份额。 越来越多地采用 3D 生物打印来製造医疗产品预计将成为促进该地区市场增长的主要因素之一。 另一方面，亚太地区有望在製药和生物製药领域看到更多的技术发展。

3D 生物打印市场报告亮点

  • 由于研发投资增加，医疗行业将在 2022 年占据最大份额，达到 37.6%。
  • 由于技术发展和各种创新者越来越多地采用磁悬浮技术，磁悬浮部分预计在预测期内将实现 13.7% 的最高复合年增长率。
  • 北美在 2022 年以 30.9% 的份额主导了市场。 增加政府对医疗保健行业的支出是推动该地区市场的主要因素之一。

内容

第一章研究方法论

  • 市场细分和范围
  • 市场定义
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 辅助技术和第三方视角
    • 初步调查
  • 信息分析
    • 数据分析模型
  • 市场形成和数据可视化
  • 验证和发布数据

第 2 章执行摘要

第 3 章行业展望：市场变量、趋势和范围

  • 市场细分和范围
  • 市场规模和增长前景
  • 3D 生物打印市场：市场动态
    • 市场驱动力分析
      • 3D 生物打印行业的技术进步
      • 慢性病患病率上升
      • 越来越多地使用 3D 生物打印在製药和美容领域
    • 市场製约因素分析
      • 3D 生物打印机的高成本
      • 缺乏训练有素的专业人员
  • 行业分析 - 搬运工
    • 供应商力量
    • 买家的议价能力
    • 替代威胁
    • 新进入者的威胁
    • 竞争公司之间的敌对关係
  • 3D 生物打印 - SWOT 分析（通过 PEST）
    • 政治形势
    • 经济状况
    • 社交情况
    • 技术概况
  • 新型冠状病毒影响分析

第 4 章 3D 生物打印市场：技术估计和趋势分析

  • 全球 3D 生物打印市场：技术波动分析
  • 磁悬浮技术
  • 喷墨技术
  • 基于注射器的技术
  • 激光技术
  • 其他

第 6 章 3D 生物打印市场：应用估计和趋势分析

  • 全球 3D 生物打印市场：应用波动分析
  • 医疗
    • 组织和器官的产生
    • 药丸
    • 假肢和植入物
    • 其他
  • 牙科
  • 生物传感器
  • 消费者/个人产品测试
  • 生物墨水
  • 食品和动物产品

第 7 章 3D 生物打印市场：按服务、技术和应用分类的区域估计和趋势分析

  • 2022 年和 2030 年按地区划分的 3D 生物打印市场份额
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 澳大利亚
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第八章竞争格局

  • 公司简介
    • Envisiontec, Inc.
      • 公司简介
      • 产品基准
      • 战略举措
    • 有机体
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Inventia Life Sciences Pty Ltd
      • 公司简介
      • 产品基准
    • POIETIS
      • 公司简介
      • 产品基准
      • 战略举措
    • VIVAX BIO, LLC
      • 公司简介
      • 产品基准
      • 战略举措
    • ALLEVI
      • 公司简介
      • 产品基准
    • Cyfuse Biomedical KK
      • 公司简介
      • 产品基准
      • 战略举措
    • 3D 生物打印解决方案
      • 公司简介
      • 产品基准
    • CELLINK 全球
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • REGEMAT 3D SL
      • 公司简介
      • 产品基准
Product Code: 978-1-68038-636-3

3D Bioprinting Market Growth & Trends:

The global 3D bioprinting market size is expected to reach USD 5.3 billion by 2030, expanding at a CAGR of 12.5% over the forecast period, according to a new report by Grand View Research, Inc. Rising cases of COVID-19 and high prevalence of chronic diseases are some of the major factors contributing to the growth. During the outbreak of the pandemic, 3D printing has stepped up to become a vital technology to support improved healthcare and emergency response.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast-tracked the development of vaccine and drug testing.

In the meantime, various 3D bioprinting companies are focused on the R&D of artificial tissues. With the help of U-FAB and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator.

The pandemic not only affected the well-being of people, but also affected the economy, and various other healthcare infrastructures worldwide. It severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situations, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to healthcare workers.

North America held the highest share of about 30.9% in 2022. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness increased technological development in the pharmaceutical and biopharmaceutical sectors.

3D Bioprinting Market Report Highlights:

  • The medical segment accounted for the largest share of 37.6% in 2022 due to the increasing investment made in R&D
  • The magnetic levitation segment is anticipated to witness the highest CAGR of 13.7% over the forecast period due to technological development, and increasing adoption of magnetic levitation techniques by various innovators
  • North America dominated the market in 2022 with a share of 30.9%. Growing government expenditure on the healthcare industry is one of the major factors driving the market in this region
  • Some of the key players include Organovo; Envision TEC; Inventia Life Science PTY LTD; Poietis; Vivax Bio, LLC; Allevi; Cyfuse Biomedical K.K.; 3D Bioprinting Solutions; Cellink Global; Regemat 3D S.L.

Table of content

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary technology & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

  • 2.1 3D Bioprinting Market Outlook, 2018 - 2030

Chapter 3 Industry Outlook: Market Variables, Trends, & Scope

  • 3.1 Market Segmentation and Scope
  • 3.2 Market Size and Growth Prospects
  • 3.3 3D Bioprinting Market: Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Technological advancement in the 3d bioprinting industry
      • 3.3.1.2 Rising prevalence of chronic disease
      • 3.3.1.3 Increasing use of 3d bioprinting in the pharmaceutical and cosmetology
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 The high cost of 3D bioprinters
      • 3.3.2.2 Lack of trained professionals
  • 3.4 Industry Analysis - Porter's
    • 3.4.1 Supplier Power
    • 3.4.2 Buyer Power
    • 3.4.3 Substitution Threat
    • 3.4.4 New Entrants Threat
    • 3.4.5 Competitive Rivalry
  • 3.5 3D Bioprinting-SWOT Analysis, By PEST
    • 3.5.1 Political landscape
    • 3.5.2 Economic landscape
    • 3.5.3 Social landscape
    • 3.5.4 Technology landscape
  • 3.6 Covid Impact Analysis

Chapter 4 3D Bioprinting Market: Technology Estimates & Trend Analysis

  • 4.1 Global 3D Bioprinting Market: Technology Movement Analysis
  • 4.2 Magnetic Levitation Technology
    • 4.2.1 Global Magnetic Levitation technology market, 2018 - 2030 (USD Million)
  • 4.3 Inkjet-based Technology
    • 4.3.1 Global Inkjet-based technology market, 2018 - 2030 (USD Million)
  • 4.4 Syringe-based Technology
    • 4.4.1 Global Syringe-based technology market, 2018 - 2030 (USD Million)
  • 4.5 Laser-based Technology
    • 4.5.1 Global Laser-based technology market, 2018 - 2030 (USD Million)
  • 4.6 Others
    • 4.6.1 Global Other technologies market, 2018 - 2030 (USD Million)

Chapter 6 3D Bioprinting Market: Application Estimates & Trend Analysis

  • 6.1 Global 3D Bioprinting Market: Application Movement Analysis
  • 6.2 Medical
    • 6.2.1 Global medical market, 2018 - 2030 (USD Million)
    • 6.2.2 Tissue and organ generation
      • 6.2.2.1 Global tissue and organ generation market, 2018 - 2030 (USD Million)
    • 6.2.3 Medical pills
      • 6.2.3.1 Global Medical pills market, 2018 - 2030 (USD Million)
    • 6.2.4 Prosthetics and implants
      • 6.2.4.1 Global Prosthetics and implants market, 2018 - 2030 (USD Million)
    • 6.2.5 Others
      • 6.2.6.1 Global others application market, 2018 - 2030 (USD Million)
  • 6.3 Dental
    • 6.3.1 Global dental market, 2018 - 2030 (USD Million)
  • 6.4 Biosensors
    • 6.4.1 Global biosensors market, 2018 - 2030 (USD Million)
  • 6.5 Consumer/Personal Product Testing
    • 6.5.1 Global consumer/personal product testing market, 2018 - 2030 (USD Million)
  • 6.6 Bioinks
    • 6.6.1 Global bioinks market, 2018 - 2030 (USD Million)
  • 6.7 Food and Animal Product
    • 6.7.1 Global food and animal market, 2018 - 2030 (USD Million)

Chapter 7 3D Bioprinting Market: Regional Estimates & Trend Analysis, by Service, Technology, & Application

  • 7.1 3D Bioprinting Market Share By Region, 2022 & 2030
  • 7.2 North America
    • 7.2.1 North America 3D Bioprinting market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.2.2.2 U.S. 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.2.3.2 Canada 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe 3D Bioprinting market, 2018 - 2030 (USD Million)
    • 7.3.2 U.K.
      • 7.3.2.1 U.K. 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.2.2 U.K. 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.3.2 Germany 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.4.2 France 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.5.2 Italy 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.6.2 Spain 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.7 Denmark
      • 7.3.7.1 Denmark 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.7.2 Denmark 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.8 Sweden
      • 7.3.8.1 Sweden 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.8.2 Sweden 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Norway 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.3.9.2 Norway 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific 3D Bioprinting market, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.2.2 Japan 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.3.2 China 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.4.2 India 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.4.5 Thailand
      • 7.4.5.1 Thailand 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.5.2 Thailand 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.4.6 Australia
      • 7.4.6.1 Australia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.6.2 Australia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.4.7 South Korea
      • 7.4.7.1 South Korea 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.4.7.2 South Korea 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America 3D Bioprinting market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.5.2.2 Brazil 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.5.3.2 Mexico 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.5.4.2 Argentina 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.5.5 Columbia
      • 7.5.5.1 Columbia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.5.5.2 Columbia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
  • 7.6 Middle East & Africa (MEA)
    • 7.6.1 Middle East & Africa 3D Bioprinting market, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.6.2.2 South Africa 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.6.3.2 Saudi Arabia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 UAE 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.6.4.2 UAE 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
    • 7.6.5 Kuwait
      • 7.6.5.1 Kuwait 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
      • 7.6.5.2 Kuwait 3D Bioprinting market, by application, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Company Profiles
    • 8.1.1 Envisiontec, Inc.
      • 8.1.1.1 Company overview
      • 8.1.1.2 Product benchmarking
      • 8.1.1.3 Strategic initiatives
    • 8.1.2 Organovo
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial performance
      • 8.1.2.3 Product benchmarking
      • 8.1.2.4 Strategic initiatives
    • 8.1.3 Inventia Life Science Pty Ltd
      • 8.1.3.1 Company overview
      • 8.1.3.2 Product benchmarking
    • 8.1.4 POIETIS
      • 8.1.4.1 Company overview
      • 8.1.4.2 Product benchmarking
      • 8.1.4.3 Strategic initiatives
    • 8.1.5 VIVAX BIO, LLC
      • 8.1.5.1 Company overview
      • 8.1.5.2 Product benchmarking
      • 8.1.5.3 Strategic initiatives
    • 8.1.6 ALLEVI
      • 8.1.6.1 Company overview
      • 8.1.6.2 Product benchmarking
    • 8.1.7 Cyfuse Biomedical K.K.
      • 8.1.7.1 Company overview
      • 8.1.7.2 Product benchmarking
      • 8.1.7.3 Strategic initiatives
    • 8.1.8 3D Bioprinting Solutions
      • 8.1.8.1 Company overview
      • 8.1.8.2 Product benchmarking
    • 8.1.9 CELLINK GLOBAL
      • 8.1.9.1 Company overview
      • 8.1.9.2 Financial performance
      • 8.1.9.3 Product benchmarking
      • 8.1.9.4 Strategic initiatives
    • 8.1.10 REGEMAT 3D S.L.
      • 8.1.10.1 Company overview
      • 8.1.10.2 Product benchmarking

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 3D bioprinting market snapshot (2022)
  • Fig. 8 Market segmentation
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 13 3D bioprinting market technology outlook: Segment dashboard
  • Fig. 14 3D bioprinting market: Technology movement analysis
  • Fig. 15 Magnetic levitation market, 2018 - 2030 (USD Million)
  • Fig. 16 Inkjet-based market, 2018 - 2030 (USD Million)
  • Fig. 17 Syringe-based market, 2018 - 2030 (USD Million)
  • Fig. 18 Laser-based market, 2018 - 2030 (USD Million)
  • Fig. 19 Others market, 2018 - 2030 (USD Million)
  • Fig. 20 3D bioprinting market application outlook: Segment dashboard
  • Fig. 21 3D bioprinting market: Application movement analysis
  • Fig. 22 Medical market, 2018 - 2030 (USD Million)
  • Fig. 23 Tissue and organ generation market, 2018 - 2030 (USD Million)
  • Fig. 24 Medical pills market, 2018 - 2030 (USD Million)
  • Fig. 25 Prosthetic and implants market, 2018 - 2030 (USD Million)
  • Fig. 26 Other medical application market, 2018 - 2030 (USD Million)
  • Fig. 27 Dental market, 2018 - 2030 (USD Million)
  • Fig. 28 Biosensors market, 2018 - 2030 (USD Million)
  • Fig. 29 Consumer/personal product testing market, 2018 - 2030 (USD Million)
  • Fig. 30 Bioinks market, 2018 - 2030 (USD Million)
  • Fig. 31 Food and animal product market, 2018 - 2030 (USD Million)
  • Fig. 32 Regional market: Key takeaways
  • Fig. 33 Regional outlook, 2022 & 2030
  • Fig. 34 North America market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market, 2018 - 2030 (USD Million)
  • Fig. 38 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market, 2018 - 2030 (USD Million)
  • Fig. 40 France market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway market, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market, 2018 - 2030 (USD Million)
  • Fig. 48 China market, 2018 - 2030 (USD Million)
  • Fig. 49 India market, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 57 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 58 MEA market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait market, 2018 - 2030 (USD Million)